Anebulo Pharmaceuticals(ANEB) - 2026 Q2 - Quarterly Results

Financial Results - Anebulo Pharmaceuticals reported financial results for Q4 2025, with a focus on business updates[5] Company Classification - The company is classified as an emerging growth company under the Securities Act[4] Stock Information - Anebulo Pharmaceuticals' common stock is traded on The Nasdaq Stock Market under the symbol ANEB[3]